Trial intelligence / Profile preview

Pentoxifylline SR for dizziness/vertigo in acute ischemic stroke

ChiCTR2100048426Phase 4Recruiting

Sponsor
Seventh Medical Center of the People's Liberation Army General Hospital
Start
May 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of pentoxifylline in ischemic stroke (2 arms), sponsored by Seventh Medical Center of the People's Liberation Army General Hospital. Primary endpoint: Dizziness Assessment Rating Scale (DARS). Started May 2020; status: recruiting.

02

Drugs

pentoxifylline
03

Conditions

ischemic stroke

Beyond the preview

Go deeper on ChiCTR2100048426.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2100048426.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call